Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 evaluation of low-volume PEG bowel cleansing solutions versus MOVIPREP in healthy volunteers and screening colonoscopy subjects
2012-003052-37Phase 2Completed
- Sponsor
- Norgine
- Start
- Aug 2012
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of macrogol, sodium ascorbate, ascorbic acid, sodium sulfate, sodium chloride and 1 more (2 arms), sponsored by Norgine. Primary endpoints: Stool output and Stool output and bowel cleansing quality. Started Aug 2012; status: completed.
02
Drugs
macrogolsodium ascorbateascorbic acidsodium sulfatesodium chloride
Beyond the preview
Go deeper on 2012-003052-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003052-37.